|
| |
Pharmaceutical Profiles helps break the habit of
ineffective early drug development decision making
May 9th 2008: Throughout May, Pharmaceutical Profiles (Ruddington, UK) is
maintaining its focus on innovative clinical and pre-clinical protocols that
support effective and efficient drug development. The company’s latest webinar
and workshop schedule includes events that address important issues, including:
gaining an early understanding of bioavailability, optimizing formulation
strategy for efficient development, and testing the feasibility of controlled
release delivery. Working with most of the world’s top pharmaceutical and
biotechnology companies, Pharmaceutical Profiles continues to challenge current
habits in decision-making in the drug development cycle.
On 21 May 2008, Dr Andy Rankin, CSO, Pharmaceutical Profiles, will lead a free
webinar: “How do we improve the speed and efficiency of achieving successful New
Drug Applications?” Following on from previously successful events of this type,
Dr Rankin will apply his extensive industry experience to challenges and
solutions for improving pharmaceutical R&D productivity.
The Second Annual Exploratory Clinical Development Congress at the Earls Court
Conference Centre in London on 16 May, sees Pharmaceutical Profiles host a one
day post-conference workshop entitled; “Successful practices in the early
clinical development of oral drugs”. Covering the critical issues facing the
development of oral drugs, leaders from pharmaceutical development, clinical
research organisations and technology providers will discuss worked examples of
study designs, technologies and decision-making used to support early clinical
development.
For further information and registration, visit
www.pharmprofiles.com.
Text ends
For further information:
Press information
Richard Kent, Kapler Communications
Tel: +44 (0)1480 479 280 Fax: +44 (0) 1480 470 343
richard@kapleronline.com
Company contact:
Karen Jones PhD, Vice President, Marketing, Pharmaceutical Profiles Ltd
Tel: +44 (0)115 974 9000
karen.jones@pharmprofiles.com
| |
|
